Novita takes heart implant from design to development with new financing
This article was originally published in Clinica
Executive Summary
Biopharmaceutical and medical device developer Novita Therapeutics has secured nearly $1m in angel financing, nearly nine months after the company was established. The Lenxa, Kansas firm said the recent completion of a fundraising tranche brought the total investment it has received since its founding in November 2009 to $930,000. The company will use the proceeds to develop an implantable cardiovascular device. In conjunction with the financing, Novita said it has signed on Cirtec Medical as its manufacturing partner.